Christopher Pocock

6k citations
76 papers · 5.1k · 4 hit papers · h-index 29

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematology top 1%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation

Papers in

Christopher Pocock

73 papers receiving 4.9k citations

Christopher Pocock's Hit Papers

Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma 2022 · 134 citations
1340+4+8Years since publication4008001.2k

Peers

Christopher Pocock
Comparison fields: 5 of 81
  • Genetics 1.6k
  • Hematology 1.3k
  • Pathology and Forensic Medicine 1.6k
  • Oncology 232
  • Geriatrics and Gerontology 20
Replace Carolyn Owen with:
Carolyn Owen Canada
Haifa Kathrin Al‐Ali Germany
Andrzej Hellmann Poland
Kamel Laribi France
Monica Tani Italy
Mathieu Monconduit France
Achiel Van Hoof Belgium
Olga S. Samoilova United States
Miklós Egyed Hungary
Marzia Varettoni Italy
Christopher Pocock relative to Carolyn Owen Canada Carolyn Owen's profile →
Citations per field
00.5×1.5×
Carolyn Owen · 1×
Citations per year

Countries citing papers authored by Christopher Pocock

Since Specialization
Citations

This map shows the geographic impact of Christopher Pocock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Pocock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Pocock more than expected).

Fields of papers citing papers by Christopher Pocock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Pocock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Pocock. The network helps show where Christopher Pocock may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Pocock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Pocock Line = papers co-authored together Christopher Pocock links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Hit paper breakdown →
20141384
2
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
Hit paper breakdown →
2013451
3
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
Hit paper breakdown →
2020325
4 2014301
5 2019212
6
Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.
1994165
7 2019149
8
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Hit paper breakdown →
2022134
9 2001132
10 2012118
11 2005110
12 2017106
13 2014103
14
Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
2000102
15 201389
16 201983
17 200377
18 201076
19 201770
20 200057

About Christopher Pocock

Christopher Pocock is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Neurology and Biochemistry, having authored 76 papers that have together received 5.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Chronic Lymphocytic Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Blood transfusion and management (1 paper). The work is most often cited by research in Genetics (1.6k citations), Hematology (1.3k citations), Pathology and Forensic Medicine (1.6k citations), Oncology (232 citations) and Geriatrics and Gerontology (20 citations). Christopher Pocock has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Peter Johnson, David C. Linch, Paul Smith, Kirit M. Ardeshna, Andrew Jack, Jane F. Apperley, David Cunningham, John Maelor Davies, Wendi Qian and John M. Goldman. Their work appears in journals such as Blood, British Journal of Haematology, Hematological Oncology, New England Journal of Medicine and The Lancet Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact